Search

everythinglearnresearchcommunity

for

Search:↓

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Some drugs may help treat both COVID-19 and radiation injury.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Alopecia areata after COVID-19 vaccination is rare but important to recognize for timely treatment.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Clausena anisata may be effective in treating acne due to its ability to fight bacteria, reduce inflammation, and possibly lower sebum production.

Targeting autophagy can help treat skin disorders like vitiligo and atopic dermatitis.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to their safety and ease of use.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Certain drugs can change hair color, either lightening or darkening it.

Alopecia Areata can affect nails, often improving on its own, but JAK inhibitors may help.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

Collagen from tilapia scales may improve hair and skin health by reducing stress and inflammation and encouraging hair growth.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Early hair greying may increase the risk of heart disease.

Depression and skin autoimmune diseases are linked, needing combined care for better treatment.